Table 3

Patient demographics, lesion characteristics, and outcomes for two-arm studies with radial and femoral arterial access arms

Study variableGao et al,
201815
Mendiz et al, 201614 Ruzsa et al, 20142 Total
RadialFemoralRadialFemoralRadialFemoralRadialFemoral
Pretreatment stenosis (±SD)86.5% (±10.2)85.1% (±10.4)85.7% (±7.5)85.0% (±8.1)82.6% (NR)84.0% (NR)
Mean age (years)72.070.071.069.766.866.7
Patients (n)2830101674130130259834
Male (n)13 (46.4%)14 (46.7%)80 (79.2%)478 (70.9%)79 (60.8%)85 (65.4%)172 (66.4%)577 (69.2%)
Lesion side (n)
 Left12 (42.9%)16  (53.3 %)44  (43.6 %)325 (48.2%)57 (43.8%)76 (58.5%)113 (43.6%)417 (50.0%)
 Right16 (57.1 %)14  (46.7 %)57 (56.4 %)349 (51.8%)73 (56.2%)54 (41.5%)146 (56.4%)417 (50.0%)
Aortic arch (n)
 Type I0012838610898191
 Type II/III1614895914422149627
 Bovine1216NRNRNRNR1216
Crossover (n)0350132185
 AA type I00007070
 AA type II–III035060112
 Bovine arch00002NR20
Procedural success without crossover28 (100%)27 (90.0%)96 (95.0%)674 (100%)117 (90.0%)128 (98.5%)241 (93.1%)829 (99.4%)
Access site hematoma0 (0%)0 (0%)1 (1.0%)NR2 (1.5%)5 (3.8%)3 (1.2%)5 (0.6%)
Access site major complications0 (0%)0 (0%)0 (0%)4 (0.6%)2 (1.5%)1 (0.8%)2 (0.8%)5 (0.6%)
Minor CVA (d≤30)0 (0%)0 (0%)1 (1.0%)21 (3.1%)0 (0%)1 (0.8%)1 (0.4%)22 (2.6%)
Major CVA (d≤30)0 (0%)0 (0%)2 (2.0%)7 (1.0%)1 (0.8%)0 (0%)3 (1.2%)7 (0.8%)
Mortality (n)0 (0%)0 (0%)0 (0%)10 (1.5%)2 (1.5%)0 (0%)2 (0.8%)10 (1.2%)
Hospitalization (days)6.46.8NRNR1.41.25
  • CVA, cerebrovascular accident; d≤30, occurring within 30 days after the procedure.